Project Grant K99DK138295
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) is providing $168,296 to Weill Medical College of Cornell University to conduct a 5-year research program on the role of a key enzyme in group 3 innate lymphoid cells (ILC3s) that regulates gut physiology. The research aims to investigate the potential links between ILC3s, gut inflammation, and gastrointestinal motility,...
- This federal Project Grant award of $726,140.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to elucidate the neural circuits and cellular mechanisms underlying visceral pain processing in the spinal cord and brainstem, with the goal of advancing understanding and treatment of visceral pain conditions such as irritable bowel syndrome,...
- This $161,695 federal Project Grant was awarded on September 3, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to elucidate the role of epithelial purinergic signaling, specifically through the P2Y1 receptor, in intestinal inflammation and repair. The principal investigator's research uses human intestinal organoids and...
- This federal Project Grant award of $136,025.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate how gut epithelial serotonin (5-HT) regulates the function of extrinsic primary afferent neurons (EPANs) and impacts visceral pain signaling. The research aims to define how availability of epithelial 5-HT affects EPAN...
- This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $169,560 to The Regents of the University of California, San Francisco (UCSF) for a project titled "Cutaneous Opioid Circuitry in Skin Inflammation and Sensation". The project aims to expand understanding of the endogenous opioid biology and circuits within the skin, with the goal...
- This $172,232 federal Project Grant award was made on September 1, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research conducted by Simon M. Gray, MD, PhD, a fellowship-trained gastroenterologist at the University of North Carolina at Chapel Hill (UNC-CH), to improve understanding of the causes of inflammatory bowel diseases (IBD) therapy...
- This Project Grant award, with $228,948.00 in funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research into the role of adrenomedullin 2 (ADM2), an understudied neuropeptide hormone, in regulating intestinal inflammation and immunity. The project aims to investigate how the ADM2-ADM2R pathway drives non-redundant group 2 innate lymphoid cell (ILC2)...
- This Project Grant award of $242,100.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research at the Mayo Clinic to explore the role of sphingolipid metabolism in regulating the function and activity of regulatory T cells in the context of inflammatory bowel disease. The research aims to elucidate the molecular mechanisms by which lipid metabolites...
- The Project Grant award of $817,866.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate alternative pain signal transmission pathways in the spinal cord. The primary focus is on understanding the functional role of a novel subset of spinal projection neurons that express the GPR83 neuropeptide receptor, in addition to the previously studied...
- The federal Project Grant award of $151,643.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on developing Proteolysis Targeting Chimeras (PROTACs) to stabilize Hypoxia-Inducible Factors (HIFs) and investigate their therapeutic potential for treating inflammatory bowel diseases. The award, effective April 11, 2025, with an ultimate completion date...
NOCICEPTOR REGULATION OF INTESTINAL INFLAMMATION AND TISSUE PROTECTION - PROJECT SUMMARY RESEARCH: INFLAMMATORY BOWEL DISEASES (IBD) ARE A GROUP OF CHRONIC INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT THAT AFFECT OVER 3 MILLION AMERICANS. ABDOMINAL PAIN IS A COMMON SYMPTOM OF IBD, BUT THE ROLE OF PAIN-SENSING NOCICEPTOR NEURONS IN REGULATING THE INFLAMMATORY PROCESS IS LARGELY UNKNOWN. BASED ON MY PUBLISHED AND NEW PRELIMINARY DATA, I HYPOTHESIZE THAT NOCICEPTOR SENSORY NEURONS AND NEUROPEPTIDES ARE TISSUE-PROTECTIVE, BUT BECOME DYSREGULATED IN THE CONTEXT IBD, AND SUBSEQUENTLY DRIVE PATHOLOGICAL ADAPTIVE IMMUNITY AND ALTERATIONS TO THE MICROBIOTA THAT FACILITATE INTESTINAL INFLAMMATION AND IMPAIR TISSUE REPAIR. THIS PROPOSAL AIMS TO THOROUGHLY INVESTIGATE THE REGULATION OF INTESTINAL INFECTION AND INFLAMMATION BY NOCICEPTOR SENSORY NEURONS AND DETERMINE THE DETAILED UNDERLYING CELLULAR AND MOLECULAR MECHANISMS USING INNOVATIVE AND INTERDISCIPLINARY APPROACHES FROM NEUROBIOLOGY, GASTROENTEROLOGY, IMMUNOLOGY AND MICROBIOLOGY. THESE STUDIES WILL UNCOVER NOVEL NEURO-IMMUNE-MICROBIOTA CROSSTALK PATHWAYS AND THEIR UNIQUE ROLES IN INTESTINAL INFLAMMATION AND TRANSFORM OUR UNDERSTANDINGS OF HOST-MICROBE INTERACTIONS AND NEURO-IMMUNE MECHANISMS IN IBD. CAREER GOALS: MY OVERARCHING CAREER GOAL IS TO BECOME AN INDEPENDENT INVESTIGATOR AT AN ACADEMIC INSTITUTION WHERE I DECIPHER THE NEURO-IMMUNE AND NEURON-MICROBIOTA PATHWAYS THAT REGULATE INTESTINAL TOLERANCE AND INFLAMMATION AND EVENTUALLY DISCOVER NEURONAL-BASED AND MICROBIOTA-BASED DRUG TARGETS FOR IMMUNE MODULATION TO TREAT CHRONIC INFLAMMATORY DISEASES INCLUDING IBD. FURTHERMORE, I ASPIRE TO BECOME AN INSPIRATIONAL TEACHER AND OUTSTANDING MENTOR. CAREER DEVELOPMENT PLAN: TO BECOME A SUCCESSFUL INDEPENDENT INVESTIGATOR I WILL FURTHER DEVELOP VARIOUS RESEARCH, PROFESSIONAL AND PERSONAL SKILLS. THESE WILL INCLUDE FURTHER ACQUIRING EXPERTISE IN NEUROBIOLOGY AND MICROBIOLOGY TECHNIQUES, AS WELL AS FOSTERING COLLABORATIONS AND DEVELOPING SKILLS IN WRITING, MENTORING, TEACHING, COMMUNICATING AND LABORATORY MANAGEMENT. MY HOST LABORATORY AND WEILL CORNELL MEDICINE PROVIDES AN OUTSTANDING ACADEMIC ENVIRONMENT IN WHICH TRAINEES CAN FULFIL THESE CRITERIA BY PROMOTING SCIENTIFIC INTERACTIONS AND ENROLLING IN COURSES TO DEVELOP SKILLS IN SPECIALIST SCIENTIFIC AREAS, PERSONAL DEVELOPMENT AND LABORATORY MANAGEMENT. THE MENTORSHIP I WILL RECEIVE WILL BE OF THE HIGHEST STANDARD. FURTHERMORE, IN ADDITION TO MY MENTOR AND CO-MENTOR, I HAVE SUPPORT FROM A TEAM OF INDEPENDENT INVESTIGATORS WITH EXTENSIVE EXPERTISE IN AREAS THAT WILL GREATLY FACILITATE THE COMPLETION OF EXPERIMENTS PROPOSED AND MY CAREER TRANSITIONAL INTO INDEPENDENCE. CAREER DEVELOPMENT ENVIRONMENT: I WILL PERFORM THE K99 PHASE IN THE LABORATORY OF DR. DAVID ARTIS AT THE WEILL CORNELL MEDICINE, WHICH PROVIDES AN UNPRECEDENTED ENVIRONMENT IN TERMS OF THE RESOURCES AND FACILITIES AVAILABLE. WEILL CORNELL MEDICINE IS AN IDEAL ENVIRONMENT TO DEVELOP DURING THE K99 PHASE AS I PROGRESS TO BECOME A SUCCESSFUL INDEPENDENT INVESTIGATOR. THE LABORATORY HAS ACCESS TO ALL OF THE EQUIPMENT AND FACILITIES NECESSARY TO COMPLETE THE EXPERIMENTS PROPOSED IN THIS APPLICATION.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $90.0k | 6/3/25 | ||
| Not listed | $91.5k | 7/11/24 | ||
| Not listed | $91.5k | 7/11/24 |